REFERENCES
1. Degtyarev D.N., Platnikov A.L. Intrauterine infections. Cytomegalovirus infection. Neonatology: National leadership. Short edition. Edited by N.N. Volodin. Moscow: GEOTAR-Media, 2013: 725–31. (in Russian)
2. Kisteneva L.B. The role of cytomegalovirus infection in the formation of perinatal pas-toology. Detskie Infektsii [Childhood Infections]. 2013; (3): 44–7. (in Russian)
3. Mussi-Pinhata M.M., Yamamoto A.Y. Natural history of congenital cytomegalovirus infection in highly seropositive populations. J Infect Dis. 2020; 221: 15–22.
4. Clinical Guidelines “Congenital Cytomegalovirus Infection”. 2022. [Electronic resourse]. https://www.raspm.ru (date of access: 09.02.2023). (in Russian)
5. Clinical Recommendations “Normal Pregnancy”. 2020. [Electronic resource]. https://cr.minzdrav.gov.ru/recomennd (date of access: 09.02.2023) (in Russian)
6. NeoCytotect. Instructions for use of the medicinal product for human use. [Electronic resource]. URL: https://www.rlsnet.ru/tn_index_id_35536.htm (date of access: 09.02.2023) (in Russian)
7. Valvir. Instructions for use of the medicinal product for human use. [Electronic resource] https://www.vidal.ru/drugs/valvir 35634 (date of access: 01.02.2023). (in Russian)
8. Shakhgildyan V.I. Head of Cytomegalovirus infection. In: Yushchuk N.D., Vengerov Yu.Ya. Lecture on Infectious Diseases. 5th ed., rev. and additional. Moscow: GEOTAR-Media. 2022; 2: 264–91. (in Russian)
9. Kagan K.O., Enders M., Schampera M.S., et al. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration. Ultrasound Obstet Gynecol. 2019; 53 (3): 383–9.
10. Shakhgildyan V.I. Congenital cytomegalovirus infection: topical questions, possible answers. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2020; 8 (4): 61–72. DOI: https://doi.org/10.33029/2308-2402-2020-8-4-61-72 (in Russian)
11. Nigro G., Adler S.P., La Torre R., Best A.M. Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005; 353 (13): 1350–62.
12. Visentin S., Manara R., Milanese L., Da Roit A. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Inft Dis. 2012; 55 (4): 497–503.
13. Dietrich M.L., Schieffelin J.S. Congenital cytomegalovirus infection. Ochsner J. 2019; (19): 123–30.
14. Shakhgildyan V.I. Shipulina O.Yu., Silz V.V., et al. Diagnosis of cytomegalovirus infection in HIV-infected pregnant women and determination of risk factors for antenatal and perinatal fetal infection with cytomegalovirus. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2005; (2): 24–9. (in Russian)
15. Leruez-Ville M., Foulon I., Pass R., Ville Y. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol. 2020; 223 (3): 330–49. DOI: http://dx.doi.org/10.1016/j.ajog.2020.02.018
16. Shahar-Nissan K., Pardo J., Peled O., et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial [published correction appears in Lancet. 2020; 396 (10257): 1070]. Lancet. 2020; 396 (10253): 779–85. DOI: http://dx.doi.org/10.1016/S0140-6736(20)31868-7
17. Leruez-Ville M., Ghout I., Bussieres L., et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 2016; 215 (4): 462.e1–e10.
18. Shakhgildyan V.I., Galina M.V., Shamshurina M.K., Silz V.V. First experience with valganciclovir for the treatment of cytomegalovirus infection in an HIV-infected pregnant woman. Epidemiologiya i infektsionnye bolezni [Epidemiology and Infectious Disease]. 2008; (3): 60–5. (in Russian)
19. Valganciclovir effective in infants with cytomegalovirus. IDWeek.2013/ Abstract LB-1/ Present October 5, 2013 // www.antibiotic.ru/index.php-article=2367
20. Kimberlin D.W., Jester P.M., Sanchez P.J., et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015; 372 (10): 933–43.
21. Valganciclovir. Primeniyu lakartyntyn primaratya dlya medicin-skogo primeniya. [Electronic resource]. https://vidal.ru/drugs/valganciclovir (date of access: 01.02.2023). (in Russian)
22. Rawlinson W.D., Boppana S.B., Fowler K.B., et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017; 17 (6): e177–88. DOI: http://dx.doi.org/10.1016/S1473-3099(17)30143-3